Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination chemotherapy--present status and problems].

H Furue1

  • 1Teikyo University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.

Oncogene·2010
Same author

Responses to 5-HT in morphologically identified neurons in the rat substantia gelatinosa in vitro.

Neuroscience·2009
Same author

Action of neuropeptide Y on nociceptive transmission in substantia gelatinosa of the adult rat spinal dorsal horn.

Neuroscience·2005
Same author

[Anti-nociceptive effect of calcitonin on chronic pain associated with osteoporosis].

Clinical calcium·2005
Same author

Functional reorganization of the spinal pain pathways in developmental and pathological conditions.

Novartis Foundation symposium·2004
Same author

Analysis of receptive fields revealed by in vivo patch-clamp recordings from dorsal horn neurons and in situ intracellular recordings from dorsal root ganglion neurons.

Life sciences·2004
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Developing effective combination chemotherapy requires combining proven drugs with different mechanisms and toxicities at adequate doses. However, definitive evidence for optimal regimens is still lacking, necessitating further clinical trials.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trials

Context:

  • Combination chemotherapy is a cornerstone of cancer treatment.
  • Numerous clinical trials have explored various combination regimens.
  • Optimizing combination chemotherapy remains a significant challenge in oncology.

Purpose:

  • To outline the established principles for designing effective clinical combination chemotherapy.
  • To highlight the ongoing need for evidence-based regimen development.
  • To identify areas for future research in combination chemotherapy.

Summary:

  • Effective combination chemotherapy involves selecting drugs with proven efficacy, distinct mechanisms of action, and different toxicity profiles.
  • Adequate dose intensity and appropriate scheduling are crucial for therapeutic success.

Related Experiment Videos

  • Simultaneous or alternating administration schedules can be employed.
  • Current evidence is insufficient to definitively establish optimal combination chemotherapy regimens.

    • Impact:

    • Provides a framework for the rational design of future combination chemotherapy trials.
    • Emphasizes the importance of rigorous prospective randomized comparisons.
    • Guides the development of more effective and less toxic cancer treatment strategies.